Healthcare Resource Utilization (HCRU) and Associated Costs Among Patients With Acute Myeloid Leukemia (AML) Treated With Oral Azacitidine as Maintenance and Those Eligible But Not Treated Using a US Claims Database
Author Type(s)
Faculty
Document Type
Abstract
Publication Date
12-2023
Journal Title
Value in Health
Department
Medicine
Disciplines
Medicine and Health Sciences
Recommended Citation
Borate, U., Seiter, K., Potluri, R., Mazumder, D., Heydendael, W., Chevli, M., Prebet, T., Strocchia, M., Vasconcelos, A., & Sieluk, J. (2023). Healthcare Resource Utilization (HCRU) and Associated Costs Among Patients With Acute Myeloid Leukemia (AML) Treated With Oral Azacitidine as Maintenance and Those Eligible But Not Treated Using a US Claims Database. Value in Health, 26 (11), S2. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/935
COinS
